373726009: Moracizine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Substance with sodium channel blocker mechanism of action (substance)\Moracizine

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Antiarrhythmic agent (substance)\Class I antiarrhythmic agent (substance)\Moracizine

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Morpholine\Moracizine

\Organic compound\Organic cyclic compound\Heterocyclic compound\Phenothiazine and/or phenothiazine derivative\Moracizine
\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carbamate ester (substance)\Moracizine
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Morpholine\Moracizine
\Organic compound\Ester\Carbamate ester (substance)\Moracizine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Moracizine	Is a	Class I antiarrhythmic agent (substance)	true	Inferred relationship	Some
Moracizine	Is a	Carbamate ester (substance)	true	Inferred relationship	Some
Moracizine	Is a	Phenothiazine (substance)	false	Inferred relationship	Some
Moracizine	Is a	Morpholine	true	Inferred relationship	Some
Moracizine	Is a	Substance with sodium channel blocker mechanism of action (substance)	true	Inferred relationship	Some
Moracizine	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sodium channel blocker	true	Inferred relationship	Some
Moracizine	Is a	Phenothiazine and/or phenothiazine derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Moricizine hydrochloride	Is a	False	Moracizine	Inferred relationship	Some
Moricizine measurement	Component	True	Moracizine	Inferred relationship	Some	1
Moracizine adverse reaction (disorder)	Causative agent (attribute)	True	Moracizine	Inferred relationship	Some	1
Allergy to moracizine	Causative agent (attribute)	False	Moracizine	Inferred relationship	Some
Product containing precisely moracizine 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some
Product containing moracizine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moracizine	Inferred relationship	Some	1
Product containing moricizine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some
Allergy to moracizine	Causative agent (attribute)	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 250 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Moracizine	Inferred relationship	Some	1
Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Moracizine	Inferred relationship	Some	1
Moracizine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moracizine	Inferred relationship	Some	1
Product containing only moracizine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moracizine	Inferred relationship	Some	1
Product containing only moracizine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moracizine	Inferred relationship	Some	1
Moricizine hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Moracizine	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1212181014	Moricizine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3664954018	Moracizine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3664955017	Moracizine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7445931000241115	moricizine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
7445941000241113	moracizine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module